Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Event Details

Filter
EuropeConference

Dry Powder Inhalers: Annual Conference


Add this event to your calendar: iCal   Google Calendar

Who should attend?

Those involved in Respiratory drug development Inhalation product development Device engineering Formulation development Scientific research Medical marketing Marketing and Business development

Details

Course Overview

The second generation of DPIs have become either established on the market or are a signifcant way along the approval process, these have been a great success story in improving inhaled drug delivery. However, we now have to tackle the technical and regulatory issues with ‘generic’ inhalers and their approval. The development of triple therapies is well underway, these bring about their own challenges of formulation and bioequivalence. Amazingly, new DPIs are still being created, with some moving in to development programs. Further, one of the areas where much study and recent guidance has been applied is in considering the patient use, compliance and human factors associated with DPIs. These linked topics are creating a whole new area that requires better understanding during product development and associated studies.

This annual conference aims to: address many of the issues around generic inhalers, provide case studies of bioequivalence testing, focus on the diffcult formulation challenges and the strategies used so that they may be overcome and to discuss in-depth patient and human factor issues when developing a DPI to gain regulatory approval.

Find out more about

  • How to develop a generic DPI: from scratch to market
  • Designing drugs for inhalation – achieving solutions
  • How much does it cost to develop a generic DPI inhaler?
  • Easyhaler device and performance under simulated real-life conditions
  • Clinical Bioequivalence of latest drugs
  • Asthma UK’s 2016 Annual Report
  • The AOS add-on device as a novel tool to improve powder dispersion
  • Parameters infuencing the performance of interactive blends for inhalation
  • Challenges of industrialisation of a novel user friendly DPI
  • Case study: comparing usability of two inhalers with the same drug but different

Who should attend

Those involved in

  • Respiratory drug development
  • Inhalation product development
  • Device engineering
  • Formulation development
  • Scientific research
  • Medical marketing
  • Marketing and Business development

Prices

TBC

Contact

Leigh White
info@management-forum.co.uk

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.